Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse

This publication has 29 references indexed in Scilit:

• An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.
  The Journal of Experimental Medicine, 1990
• Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats
  Clinical and Experimental Immunology, 1990
• γ‐Interferon‐Induced Activation of Latent Transforming Growth Factor‐β by Human Monocytes
  Annals of the New York Academy of Sciences, 1990
• In vivotreatment of rats with monoclonal antibodies against gamma interferon: effects on experimental allergic neuritis
  Acta Neurologica Scandinavica, 1989
• Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.
  The Journal of Experimental Medicine, 1987
• EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON
  Published by Elsevier ,1987
• Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.
  The Journal of Experimental Medicine, 1985
• Suppression of chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs by administration of liposome-associated myelin basic protein
  Journal of Neuroimmunology, 1984
• Astrocytes present myelin basic protein to encephalitogenic T-cell lines
  Nature, 1984
• Suppression of Experimental Allergic Encephalomyelitis by Interferon
  Immunological Communications, 1981